Literature DB >> 12901439

Preparation of floating alginate gel beads for drug delivery to the gastric mucosa.

Yoshifumi Murata1, Kyoko Kofuji, Susumu Kawashima.   

Abstract

Alginate gel beads containing ethylcellulose (ALECs) were prepared and investigated with regard to buoyancy, in vitro and in vivo drug release profiles, and drug targeting specificity in the gastric mucosa. When the ethylcellulose (EC) content of ALECs containing metronidazole (MZ) was higher than 3%, the beads floated in all test solutions with a specific gravity of approx. 1.01. ALECs containing 5% EC released MZ gradually and floated throughout the experimental period in simulated gastric juice (pH 1.2), and all of the drug had been released after 90 min. When we orally administered ALECs to guinea pigs, about 85% of the incorporated MZ was released at 1 h. The MZ concentration of the gastric mucosa after administration of ALECs was greater than that observed with administration of MZ solution, despite lower serum concentrations. Furthermore, the similar data were obtained for ALECs with 7% EC. These results suggest that ALECs may become a practical vehicle for delivering drugs to the gastric mucosa.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12901439     DOI: 10.1163/15685620360674263

Source DB:  PubMed          Journal:  J Biomater Sci Polym Ed        ISSN: 0920-5063            Impact factor:   3.517


  3 in total

1.  Stomach-specific drug delivery of 5-fluorouracil using floating alginate beads.

Authors:  Neeta Gupta; Nidhi Aggarwal
Journal:  AAPS PharmSciTech       Date:  2007-06-22       Impact factor: 3.246

2.  Floating drug delivery of nevirapine as a gastroretentive system.

Authors:  Hari Bn Vedha; Reddy A Brahma; Rani B Samyuktha
Journal:  J Young Pharm       Date:  2010-10

3.  Preparation and evaluation of berberine alginate beads for stomach-specific delivery.

Authors:  Zhen-Hai Zhang; Yong-Shun Sun; Hui Pang; Were L L Munyendo; Hui-Xia Lv; Sheng-Liang Zhu
Journal:  Molecules       Date:  2011-12-14       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.